Literature DB >> 15886246

Transfection of antisense chorionic gonadotropin beta gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis.

Anna Lissa Hamada1, Koji Nakabayashi, Asomi Sato, Kenji Kiyoshi, Yukou Takamatsu, Jovelle B Laoag-Fernandez, Noriyuki Ohara, Takeshi Maruo.   

Abstract

CONTEXT: Choriocarcinoma cells not only synthesize human chorionic gonadotropin (hCG), but also express LH/CG receptors on the cell membrane. This suggests that the hCG and LH/CG receptors may play a role in regulating the biological function of choriocarcinoma cells in an autocrine/paracrine manner. OBJECTIVE AND METHODS: The objective of this study was to ascertain whether the inhibition of CGbeta gene expression in choriocarcinoma cells affects their proliferation and apoptosis. Expression vector bearing antisense CGbeta gene was transfected into the choriocarcinoma cell line, JAr. CGbeta protein synthesis was monitored by Western immunoblot, and CGbeta mRNA expression was determined by RT-PCR. Cell proliferation was assessed by 3-[4,5-dimethlthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay and nuclear incorporation of 5-bromo-2'-deoxyuridine, and the apoptosis-positive rate was assessed by terminal deoxynucleotidyltransferase-mediated deoxy-UTP nick end labeling analysis and nuclear staining with Hoechst 32258.
RESULTS: JAr cells transfected with antisense CGbeta gene (JAr-aCGbeta cells) showed a significant decrease in hCG production and cell proliferation compared with untransfected and mock-transfected cells. The apoptosis-positive rate of the JAr-aCGbeta cells significantly increased compared with that of the controls. LH/CG receptor expression in JAr-aCGbeta cells decreased compared with that in controls. By contrast, supplementation of exogenous hCG significantly increased the LH/CG receptor expression and viability of JAr-aCGbeta cells.
CONCLUSIONS: These results suggest that hCG, through its binding to the LH/CG receptor, may augment proliferation and inhibit apoptosis in choriocarcinoma JAr cells, and that the introduction of an antisense gene may be a potential approach to the inhibition of choriocarcinoma cell growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886246     DOI: 10.1210/jc.2004-2458

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

Review 1.  Endometrial responses to embryonic signals in the primate.

Authors:  Prajna Banerjee; Asgerally T Fazleabas
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

2.  Expression of human chorionic gonadotropin beta-subunit type I genes predicts adverse outcome in renal cell carcinoma.

Authors:  Kristina Hotakainen; Susanna Lintula; Börje Ljungberg; Patrik Finne; Annukka Paju; Ulf-Håkan Stenman; Jakob Stenman
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

3.  HCG variants, the growth factors which drive human malignancies.

Authors:  Laurence A Cole
Journal:  Am J Cancer Res       Date:  2011-11-20       Impact factor: 6.166

Review 4.  Extragonadal actions of chorionic gonadotropin.

Authors:  Prajna Banerjee; Asgerally T Fazleabas
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

Review 5.  New discoveries on the biology and detection of human chorionic gonadotropin.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2009-01-26       Impact factor: 5.211

6.  CGB activates ERK and AKT kinases in cancer cells via LHCGR-independent mechanism.

Authors:  Aleksandra Głodek; Anna Jankowska
Journal:  Tumour Biol       Date:  2014-02-20

7.  The pregnancy hormones human chorionic gonadotropin and progesterone induce human embryonic stem cell proliferation and differentiation into neuroectodermal rosettes.

Authors:  Miguel J Gallego; Prashob Porayette; Maria M Kaltcheva; Richard L Bowen; Sivan Vadakkadath Meethal; Craig S Atwood
Journal:  Stem Cell Res Ther       Date:  2010-09-13       Impact factor: 6.832

Review 8.  Gonadotropins in doping: pharmacological basis and detection of illicit use.

Authors:  U-H Stenman; K Hotakainen; H Alfthan
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

Review 9.  Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium.

Authors:  S Haider; M Knöfler
Journal:  Placenta       Date:  2008-11-22       Impact factor: 3.481

10.  Transgenesis-mediated reproductive dysfunction and tumorigenesis: effects of immunological neutralization.

Authors:  Ruchi Sachdeva; Neetu Bhardwaj; Ilpo Huhtaniemi; Usha Aggrawal; Swatantra Kumar Jain; Rana Zaidi; Om Singh; Rahul Pal
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.